CFO Roop Kalyan Lakkaraju's Stock Transactions in Bio-Rad Laboratories

This Form 4 filing reports stock transactions by Roop Kalyan Lakkaraju, EVP and Chief Financial Officer of Bio-Rad Laboratories, Inc. On April 24, 2026, the officer received 1,078 shares of Class A common stock through the vesting of restricted stock units (RSUs) at $0 per share, increasing his total holdings to 2,983.895 shares. On the same day, he disposed of 420 shares at $287.84 per share through a transaction coded as "F" (likely a tax withholding or other mandatory disposition), resulting in a post-transaction holding of 2,563.895 shares. The filing also notes that the officer holds 2,156 additional RSUs that remain unvested, with the original grant of 4,311 RSUs on April 24, 2024, vesting in four equal annual installments. The transactions were reported on April 27, 2026.